Gürbüz Görümlü

Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl‐2 protein level in hormone‐refractory prostate cancer cells

Bülent Karabulut, Çiğdem Erten, Mustafa Gül et al. · Cell Biology International · 2008 · 42 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Urology +14

Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination

Ercüment Cengiz, Burçak Karaca, Yüksel Küçükzeybek et al. · Molecular Biology Reports · 2009 · 35 citations

Urology, Medicine, Pharmacology +7

Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145

Yüksel Küçükzeybek, Mustafa Gül, Ercüment Cengiz et al. · Journal of Experimental & Clinical Cancer Research · 2008 · 27 citations · Full text

Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells

Harika Atmaca, Gürbüz Görümlü, Burçak Karaca et al. · European Cytokine Network · 2009 · 26 citations

Synergistic Induction, Zoledronic Acid, Angiogenesis +15

Regulation of growth factors in hormone‐ and drug‐resistant prostate cancer cells by synergistic combination of docetaxel and octreotide

Çiğdem Erten, Burçak Karaca, Yüksel Küçükzeybek et al. · British Journal of Urology · 2009 · 23 citations

Synergistic Combination, Pathology, Cell Death +16